UVA testing treatment for enlarged prostate symptoms

uva health systemUniversity of Virginia Health System researchers have opened a national clinical trial examining a non-surgical treatment for lower urinary tract symptoms caused by an enlarged prostate.

Also known as benign prostatic hyperplasia (BPH), an enlarged prostate is a common condition unrelated to cancer that affects about 210 million men worldwide, according to researchers from UVA’s Division of Interventional Radiology and Department of Urology. By age 80, 9 of 10 men have an enlarged prostate, with half of these men experiencing symptoms. Symptoms can include frequent urination, painful urination, an urgent need to urinate, excessive nighttime urination, weak urine stream and incomplete emptying of the bladder.

 

How the Study Treatment Works

UVA is among a few sites in the U.S. examining the safety and effectiveness of a procedure called prostatic artery embolization (PAE). Pioneered by interventional radiologists in Europe and Latin America, PAE may provide a potential alternative to other available invasive surgical treatments.

During a PAE procedure, doctors make a tiny nick in the groin and guide a small tube called a microcatheter into the small arteries that supply the prostate with blood. Microparticles are injected into the arteries to block blood flow to the prostate, with the goal of shrinking the prostate and improving unpleasant urinary symptoms.

“We’re excited to study this nonsurgical option for prostate symptoms, hopefully sparing men the risks of incontinence and sexual dysfunction, in the setting of this U.S. Food and Drug Administration-monitored clinical study,” said Ziv J. Haskal MD, FSIR, the trial’s Principal Investigator and Professor of Radiology at the UVA School of Medicine.

Data from the largest clinical trial to date reported sustained improvement in symptoms for 72 percent of men three years after receiving the investigational treatment.

 

Enrollment Information

Researchers expect to enroll 50 to 80 men, ages 45 to 80, with symptoms due to BPH who are not responding to medications or do not wish to be treated with surgery or medications.

Anyone interested in participating in this study should contact Brigitte Kelly at 434.297.7136 or bjk3c@virginia.edu. The trial is IRB No. 18236.

More information about the trial is available here: http://www.healthsystem.virginia.edu/patients/clinicaltrials/clinicaltrial18236

uva basketball team of destiny
Team of Destiny: Inside Virginia Basketball’s Run to the 2019 National Championship, by Jerry Ratcliffe and Chris Graham, is now available at a special pre-sale discounted price of $20. The book is expected to ship by May 15, 2019, and expected to retail for $25.
Pre-order for $20: click here.


The book, with additional reporting by Scott Ratcliffe and Zach Pereles, will take you from the aftermath of the stunning first-round loss to UMBC in 2018, and how coach Tony Bennett and his team used that loss as the source of strength, through to the ACC regular-season championship, the run to the Final Four, and the thrilling overtime win over Texas Tech to win the 2019 national title, the first in school history.
 
augusta free press

Shop Google


Comments

%d bloggers like this: